Regeneron Pharmaceuticals, Inc… (NASDAQ:REGN)

Top Baird Health Care and Biotech Picks Have Massive Upside Potential

Posted: August 27, 2019 at 7:25 am

The more disruptive the market is, the more we look for companies that are not affected by the daily sturm and drang of the news cycle because they have supply ...
Read Full Story »

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Posted: August 8, 2019 at 1:05 pm

The stock market has experienced yet another 5% correction after hitting all-time highs just in July. What really stands out for 2019, particularly if you just followed the emotions of ...
Read Full Story »

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Posted: July 9, 2019 at 4:45 pm

While the public wants more pharmaceuticals and biotech advancements to treat the endless number of ailments or to extend their lives, there is a simultaneous push to make drugs more ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Array Bio, Bank of America, Oracle, Pinterest, RingCentral, Snap, SunPower, Twilio, Xilinx and More

Posted: June 18, 2019 at 8:54 am

Stocks were indicated to open higher on Tuesday after a small gain in the Dow and S&P 500 on Monday. It may be the summer, but investors need to be ...
Read Full Story »

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Posted: April 24, 2019 at 12:55 pm

When the stock market is hitting record highs, it's important to remember that it's really a market of stocks rather than a stock market. Not all companies are created equal. ...
Read Full Story »

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

Posted: April 8, 2019 at 11:10 am

Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) have announced a collaboration to discover, develop and commercialize new RNA interference (RNAi) therapeutics for a broad range of ...
Read Full Story »

Great News for Adolescents with Moderate to Severe Atopic Dermatitis

Posted: March 11, 2019 at 4:14 pm

In an incredible move for adolescent patients 12 to 17 years of age, the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for patients with moderate-to-severe atopic dermatitis. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Bed Bath & Beyond, CBOE, eBay, Etsy, Intel, Netflix, Nokia, Snap, UTC, Vonage and More

Posted: January 4, 2019 at 10:20 am

Stocks surged on Friday's strong payrolls report, but that only recaptured some of Thursday's more than 600-point drop in the Dow Jones industrials. Investors have become used to the notion ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

Posted: December 14, 2018 at 9:14 am

The futures traded down triple digits Friday morning as investors digested a very volatile trading week. Continued positive talk on trade, with China acknowledging the resumption of soybean and oil ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Achaogen, Apple, Athenahealth, Crocs, Disney, Finisar, Jabil, Michael Kors, Occidental, Starbucks and More

Posted: November 12, 2018 at 9:10 am

Stocks were indicated lower on Monday on additional trade concerns between China and the United States, even with OPEC expected to lower oil production. Investors have seen lower upside after ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

Posted: September 27, 2018 at 4:08 pm

September 27, 2018: The S&P 500 closed up 0.3% at 2,914.07. The DJIA closed up 0.2% at 26,440.41. Separately, the Nasdaq closed up 0.7% at 8,041.97. Thursday was a positive ...
Read Full Story »

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Posted: September 27, 2018 at 8:35 am

More and more, the companies that we cover on Wall Street are starting to agree that while the future's still bright for the U.S. economy, it may be one of ...
Read Full Story »

New Osteoarthritis Treatment Could Precipitate Another Blockbuster Drug

Posted: August 16, 2018 at 12:55 pm

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) both saw handy gains on Thursday after the companies posted positive topline results from their late-stage trial of ...
Read Full Story »

What the FDA Has to Say About Regeneron’s Eylea

Posted: August 15, 2018 at 9:35 am

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is facing some difficulty after it received an update from the U.S. Food and Drug Administration (FDA). Essentially, the agency issued a complete response letter ...
Read Full Story »

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

Posted: June 1, 2018 at 10:30 am

It's no surprise that it was only a matter of time before the usage and storage of big data and analytics would come to the health care sector, and many ...
Read Full Story »